Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ark Health vs Obu Health

Ark Health
Graded #406

Lower grade

vs+3.1000000000000014
Obu Health
Graded #332

Higher grade

The verdict

Obu Health takes it — 59.9/100 to 56.8/100.

Obu Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Obu Health is a Las Vegas-based multi-product telehealth platform offering compounded semaglutide from $190/month and compounded tirzepatide from $239/month, plus NAD+ and sermorelin add-ons.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueObu Health +10
34
44
Dose & formulationArk Health +24
88
64
Clinical oversightObu Health +25
59
84
Labs & monitoringObu Health +1
52
53
FulfillmentObu Health +18
56
74
Contract termsArk Health +24
55
31
Ark Health · left barObu Health · right bar

The numbers

MetricArk HealthObu Health
WeighScore56.8/10059.9/100
GradeCC
Scorecard rank#406#332
Semaglutide$1,399/mo (brand Ozempic)$190/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$1,499/mo (brand Mounjaro)$239/mo (starting dose, plus a separate fee, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Ark Health

Graded #406 · C

Strengths

  • Broadest menu in the directory — compounded sema/tirz injection, oral sema, brand Ozempic and Mounjaro, Sermorelin, MIC/B12
  • Consistent pricing at all dosages — flat rate, no escalation as you titrate up
  • Compounded oral semaglutide at $125/mo is competitive for a niche most providers don't offer
  • Free expedited shipping included
  • Phone support published (uncommon among DTC platforms)

Where it loses points

  • States served not listed — can't confirm coverage in your state without contacting support
  • LegitScript status not disclosed — no badge or verifiable ID
  • FDA compounded-medication disclaimer not displayed
  • Medical director / clinical lead not named — only generic 'certified healthcare providers'
  • Pharmacy partner not named; 503A vs 503B unspecified
Obu Health

Graded #332 · C

Strengths

  • LegitScript-certified with publicly displayed ID (44206977)
  • Two named 503A compounding-pharmacy partners (Manifest Pharmacy SC + RX Compounding Store FL) — transparency above category baseline
  • Lower advertised semaglutide starting price ($190) than most multi-product peer platforms
  • Multi-product offering (GLP-1s + NAD+ + sermorelin + generic ED + birth control) for single-platform users
  • 24-hour US board-certified physician response window

Where it loses points

  • Per-dose pricing tiers not transparently published on product pages — only 'starting from' prices visible
  • No explicit state-coverage list disclosed; FAQ confirms restrictions exist 'based on state' without enumeration
  • Medical director not named publicly
  • No published consultation fee disclosure — unclear whether physician visit is included in medication price
  • All sales final per FAQ ('Federal and State law do not allow medication returns')

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard